Andrew L. Faber - Concepedia

Author

Andrew L. Faber

Also Known As

A.L. Faber, Andrew Faber, Andrew L. Faber, Andrew Lee Faber

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Andrew L. Faber is an author at Eli Lilly (United States) specializing in medicine, cancer research, and immunology.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	1.3K
2	Cell Biology	2	2	1.3K
3	Natural Sciences	1	1	15
4	Biochemistry	1	1	15
5	Chemical Biology	1	1	15

Andrew L. Faber

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer John D. Carpten, Andrew L. Faber, Candice L. Horn, Nature Somatic VariantMedicinePleckstrin Homology DomainCancer GeneticsSystems Biology	2007	1.3K
Differences in Host Susceptibility to Disease Progression in the Human Challenge Model of<i>Haemophilus ducreyi</i>Infection Stanley M. Spinola, Cliffton T. H. Bong, Andrew L. Faber, Infection and Immunity Human Challenge ModelDisease ProgressionSusceptible HostImmunologyBacterial Pathogens	2003	41
Abstract 5245: Identification and characterization of the IDO1 inhibitor LY3381916 Frank C. Dorsey, Karim A. Benhadji, Lillian Sams, Cancer Research Drug TargetImmunologyImmunoeditingImmunotherapeuticsImmunotherapy	2018	15
Abstract P142: Preclinical characterization of LOX-22783, a highly potent, mutant-selective and brain-penetrant allosteric PI3Kα H1047R inhibitor Anke Klippel, Rui Wang, Loredana Puca, Molecular Cancer Therapeutics	2021	11

Page 1